| 4-HNE | 4-hydroxy-2-nonenal |
| AAPC | Average annual percentage change |
| ADC | Adenocarcinoma |
| AKT | Protein kinase B |
| APC | Annual percentage change |
| ARIMA | Autoregressive integrated moving average |
| ASIR | Age-standardised incidence rate |
| ASR | Age-standardised rate |
| BAPC | Bayesian age–period–cohort |
| BMI | Body mass index |
| BRICS | Brazil, Russia, India, China and South Africa |
| CI | Confidence interval |
| CIMP | CpG island methylator phenotype |
| CISNET | Cancer Intervention and Surveillance Modeling Network |
| CRC | Colorectal cancer |
| DALY | Disability-adjusted life year |
| DASH | Dietary Approaches to Stop Hypertension |
| EOCRC | Early-onset colorectal cancer |
| ERK | Extracellular signal-regulated kinase |
| FIT | Faecal immunochemical test |
| GBD | Global Burden of Disease |
| GLOBOCAN | Global Cancer Observatory estimates of cancer incidence and mortality |
| HDI | Human Development Index |
| HR | Hazard ratio |
| IBD | Inflammatory bowel disease |
| IGF-1 | Insulin-like growth factor 1 |
| IL-6 | Interleukin 6 |
| IRR | Incidence rate ratio |
| LRAU | Long-term or recurrent antibiotic use |
| MAPK | Mitogen-activated protein kinase |
| MDA | Malondialdehyde |
| MMP | Matrix metalloproteinase |
| MP | Microplastic |
| mTOR | Mechanistic target of rapamycin |
| NEN | Neuroendocrine neoplasm |
| NF-κB | Nuclear factor kappa B |
| OR | Odds ratio |
| PFAS | Per- and polyfluoroalkyl substances |
| PFOA | Perfluorooctanoic acid |
| PFOS | Perfluorooctane sulfonate |
| PI3K | Phosphoinositide 3-kinase |
| PKC | Protein kinase C |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PSC | Primary sclerosing cholangitis |
| RR | Relative risk |
| SDI | Socio-demographic Index |
| TMAO | Trimethylamine N-oxide |
| TNF-α | Tumour necrosis factor alpha |
| UPF | Ultra-processed food |